Join Growin Stock Community!
Beta
Back to OXY.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

OXY Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, OXY's total operating expenses reached $245M USD, driven entirely by SG&A expenses, as R&D expenses reported no data for the period. This marks a notable decline from Q4'25's total of $203M USD, primarily due to the absence of R&D contributions. Over the period from Q2'23 to Q1'26, operating expenses exhibited a volatile yet overall downward trend, starting at $379M USD in Q2'23 and peaking at $419M USD in Q4'23 before stabilizing around $300M-$350M USD through 2024 and early 2025. R&D expenses fluctuated significantly, declining sharply from $125M USD in Q3'23 to $45M USD in Q4'25 with intermittent recoveries, while SG&A expenses remained relatively stable at $250M-$280M USD until a drop to $158M USD in Q4'25 followed by a rebound to $245M USD in Q1'26, highlighting cost management efforts amid varying business demands.